Overview

Company Profile

MYOS RENS is an emerging BioNutrition and BioTherapeutics  company focused on the discovery, development and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases.

View Detailed Stock Data

Stock Snapshot

MYOS Symbol
Nasdaq Market
Market Cap
Price
Change
Volume
View IR Calendar

Events

A replay is available until February 9, 2019 and may be accessed by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers, using the Conference ID# 13684940.

Webcast